Bayer (OTCMKTS:BAYRY) Shares Pass Below Fifty Day Moving Average of $15.64

Share on StockTwits

Bayer AG (OTCMKTS:BAYRY) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $15.64 and traded as low as $15.35. Bayer shares last traded at $15.41, with a volume of 100,247 shares.

BAYRY has been the topic of a number of recent analyst reports. Deutsche Bank cut shares of Bayer from a “buy” rating to a “hold” rating in a report on Sunday, March 31st. Bryan, Garnier & Co cut shares of Bayer from a “neutral” rating to a “sell” rating in a report on Thursday, March 28th. Berenberg Bank initiated coverage on shares of Bayer in a report on Monday, April 1st. They set a “hold” rating on the stock. ValuEngine cut shares of Bayer from a “sell” rating to a “strong sell” rating in a report on Monday, April 1st. Finally, Bank of America reiterated a “neutral” rating on shares of Bayer in a report on Monday, March 25th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company’s stock. Bayer presently has an average rating of “Hold”.

The company has a current ratio of 1.59, a quick ratio of 1.04 and a debt-to-equity ratio of 0.80. The firm has a market cap of $57.67 billion, a P/E ratio of 8.83, a P/E/G ratio of 0.73 and a beta of 0.99.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4380214/bayer-otcmktsbayry-shares-pass-below-fifty-day-moving-average-of-15-64.html.

About Bayer (OTCMKTS:BAYRY)

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Featured Article: What is net income?

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

MKM Partners Lowers ADTRAN  Price Target to $17.00
MKM Partners Lowers ADTRAN Price Target to $17.00
Apple  PT Raised to $180.00 at Nomura
Apple PT Raised to $180.00 at Nomura
Advaxis  Lowered to “Hold” at ValuEngine
Advaxis Lowered to “Hold” at ValuEngine
Zacks Investment Research Upgrades Atlas Air Worldwide  to “Hold”
Zacks Investment Research Upgrades Atlas Air Worldwide to “Hold”
Apple  Raised to “Outperform” at Raymond James
Apple Raised to “Outperform” at Raymond James
Zacks Investment Research Lowers Agilysys  to Hold
Zacks Investment Research Lowers Agilysys to Hold


© 2006-2019 Ticker Report